Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

Operation of a Facility for Testing Malaria Vaccines in Adult Human Subjects

Solicitation Number: NIHAO2012069
Agency: Department of Health and Human Services
Office: National Institutes of Health
Location: National Institute of Allergy & Infectious Diseases/AMOB
  • Print

Note:

There have been modifications to this notice. To view the most recent modification/amendment, click here
:
NIHAO2012069
:
Solicitation
:
Added: Mar 02, 2012 9:44 am
The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for contractors that can perform malaria vaccine testing, challenge studies and infection research in humans. The contractors will also be involved in clinical protocol development. Successful offerors will need to demonstrate understanding of the relevant science/ issues related to vaccine testing and infectivity studies for the particular NIAID selected pathogens, possess appropriately trained and experienced personnel and the necessary facilities. The Government anticipates issuing a request for proposals (RFP) approximately on March 16, 2012, and selecting more than one offeror for a seven-year Indefinitely Delivery Indefinite Quantity (task order) contracts approximately in March of 2013.
Please consult the list of document viewers if you cannot open a file.

Solicitation 1

Type:
Solicitation
Posted Date:
June 8, 2012
LMIV; RFP.pdf (696.76 Kb)
Description: This action posts the solicitation for proposals furnishing the services detailed in the Statement of Work (Attachment 3). Proposals will be accepted at the place specified in, and in the number of copies specified in Attachment 1, "Packaging and Delivery of the Proposal," until 11:00 A.M. local time on Sept. 10, 2012.

Amendment 1

Type:
Mod/Amendment
Posted Date:
September 6, 2012
Description: Amendment 001

Amendment 2

Type:
Mod/Amendment
Posted Date:
September 27, 2012
Description: Amendment No. 2

Amendment 3

Type:
Mod/Amendment
Posted Date:
November 2, 2012
Description: The purpose of this amendment is to provide responses to questions received by potential offerors (see attachment). The due date for proposals is extended to January 8, 2013, at 11:30 A.M. EST.
:
10401 Fernwood Drive, Suite 2NE70, MSC 4811
Bethesda, Maryland 20817
:
All locations from where offerors could ensure delivery of fresh human specimens (peripheral blood mononuclear cells) to the NIAID-LMIV site in Rockville, Maryland, within two hours of initial processing .

United States
:
Ivan Hernandez,
Contracts Specialist
Phone: 301-402-6954
Fax: 301-480-0689
:
Terrie L Nestor,
Contracting Officer
Phone: 301-402-6790
Fax: 301-480-0689